Blood Test for Breast Cancer: What It Can and Cannot Tell You

Is There a Blood Test for Breast Cancer?

No blood test can diagnose breast cancer on its own. There is no blood test that screens the general population for breast cancer, and no result can rule cancer in or out. Breast cancer is confirmed through imaging and a tissue biopsy, not a laboratory blood draw. When people search for a blood test for breast cancer, they are usually thinking of tumor markers, which are proteins measured in blood. These markers have a narrow role: they help doctors follow a cancer that has already been diagnosed, not find it in the first place.

This distinction matters. A reassuring blood result is not proof of health, and an abnormal one is not a diagnosis. Any concern about a breast lump, skin change, or nipple discharge should be evaluated with a clinical exam and imaging, not a blood panel. Blood testing can tell you about your general health, but it is not a shortcut to breast cancer detection.

What Breast Cancer Tumor Markers Measure

Tumor markers are substances that may be produced by cancer cells or by the body in response to cancer. Several are sometimes measured in breast cancer care, but none is a screening test.

Because these proteins can be produced by healthy tissue or by non-cancerous conditions, a single measurement is hard to interpret. Doctors read them over time, alongside scans and symptoms, in people already known to have cancer. A rising marker may suggest that a treatment is not working, while a falling one may suggest it is. Used this way, markers add information. Used as a screening test in a healthy person, they mostly add confusion.

Why Tumor Markers Are Not Screening Tests

A screening test must reliably find disease early in people without symptoms while producing few false alarms. Tumor markers fail that bar for breast cancer. Levels can be normal in someone who has cancer, and they can be elevated in someone who does not. Common benign causes of a raised marker include liver disease, inflammation, pregnancy, and other cancers.

For that reason, major guidelines do not recommend tumor markers to screen average-risk people for breast cancer. Using them this way can create anxiety from false positives and false comfort from false negatives, while missing the imaging tests that actually detect early disease. A normal marker result should never be used to delay a mammogram or to dismiss a lump that can be felt.

How Breast Cancer Screening Actually Works

Screening for breast cancer is done with mammography, sometimes combined with a clinical breast exam. For most women at average risk, guidelines recommend mammograms every two years starting at age 40 and continuing through age 74. Women at higher risk, such as those with certain gene mutations or a strong family history, may start earlier and add breast MRI.

Risk is not the same for everyone. Factors that can raise risk include older age, a family history of breast or ovarian cancer, certain inherited gene changes, dense breast tissue, and prior chest radiation. A clinician can help you decide when to start and how often to screen. The key point is that screening follows guideline-based imaging, not blood work. If you have symptoms or a new finding, the next step is a diagnostic mammogram or ultrasound and, when needed, a biopsy.

Other Blood Tests a Doctor May Order

Blood work still has a place in breast cancer care, just not as a screening tool. A complete blood count (CBC) can show anemia or infection. A comprehensive metabolic panel (CMP) checks liver and kidney function, which can matter before or during treatment. In someone with a known diagnosis, markers such as CA 15-3 may help track how a treatment is working.

These tests support general health assessment and treatment monitoring. They do not detect breast cancer on their own, and a normal result on any of them should not be read as proof that no cancer is present.

How to Order a Blood Test and Where to Get Tested

Direct-access testing lets you order common blood panels online without a doctor's order, then visit a local collection site for the draw. You can request a CBC, a CMP, or a marker panel if you simply want the information. Results usually arrive within one to three business days.

For anything related to breast cancer screening, see a clinician. Ordering a tumor marker on your own is unlikely to be useful and can be misleading. Use direct access for general wellness panels, and use guideline-based imaging for screening. If a direct-access result is unexpected, bring it to a clinician rather than acting on it alone.

How Much Does It Cost?

Costs vary by panel and location. A basic CBC typically runs about $30 to $60, a CMP about $40 to $90, and individual tumor markers about $50 to $150 each. A bundled cancer marker panel can reach $200 or more. Insurance may cover medically necessary testing, while direct-access testing is usually paid out of pocket. Screening mammograms are billed separately and are often covered as preventive care.